Theriva Biologics Investor Relations Material
Latest events
Q4 2023
Theriva Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Theriva Biologics Inc
Access all reports
Theriva Biologics Inc. is a clinical-stage biotechnology company developing novel therapies for cancer and other serious diseases. The company focuses on oncolytic viruses and microbiome-based therapies designed to enhance the effectiveness of existing treatments and improve patient outcomes. Theriva’s pipeline includes investigational products targeting solid tumors, gastrointestinal diseases, and other conditions. The company is headquartered in Rockville, Maryland, and its shares are listed on the NYSE.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
TOVX
Country
🇺🇸 United States